Concepedia

Grant Wickman

GW

15

Publications

1.6K

Citations

14

H-Index

1990

Active since

Affiliations

Cancer Research UK Scotland Institute(Current)

Zymeworks (Canada)

Pfizer (United States)

University of Alberta

University of British Columbia

Grant Wickman is an author at Cancer Research UK Scotland Institute specializing in medicine, cell biology, and tumor biology.

Top concepts

Publications per year

1990–2023

15

Publications

15

Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3

Dana D. Hu‐Lowe, Helen Y. Zou, Maren L. Grazzini et al. · Clinical Cancer Research · 2008 · 620 citations

Blebs produced by actin–myosin contraction during apoptosis release damage-associated molecular pattern proteins before secondary necrosis occurs

Grant Wickman, Linda Julian, Katerina Mardilovich et al. · Cell Death and Differentiation · 2013 · 186 citations · Full text

LIM kinases are required for invasive path generation by tumor and tumor-associated stromal cells

Rebecca W. Scott, Steven Hooper, Diane Crighton et al. · The Journal of Cell Biology · 2010 · 174 citations · Full text

, , +23

An anti-HER2 biparatopic antibody that induces unique HER2 clustering and complement-dependent cytotoxicity

Nina E. Weisser, Mário Sanches, Eric Escobar-Cabrera et al. · Nature Communications · 2023 · 141 citations · Full text

Targeting Activin Receptor-Like Kinase 1 Inhibits Angiogenesis and Tumorigenesis through a Mechanism of Action Complementary to Anti-VEGF Therapies

Dana D. Hu‐Lowe, Enhong Chen, Lianglin Zhang et al. · Cancer Research · 2011 · 132 citations · Full text

, , +16

Rows per page

1–5 of 15